Waters' (WAT) Earnings And Revenues Beat Estimates In Q4
Zacks Investment Research | Jan 23, 2019 12:04AM ET
Waters Corporation (NYSE:WAT) delivered fourth-quarter 2018 non-GAAP earnings of $2.87 per share, surpassing the Zacks Consensus Estimate by 22 cents. The figure increased 14.3% on a year-over-year basis and 49.5% sequentially.
Net sales surged 23.7% sequentially and 4.1% year over year to $715.02 million. Further, the figure outpaced the Zacks Consensus Estimate of $702.52 million.
Top-line growth can be attributed to robust performance of the company’s TA product line. Further, its solid momentum in Asia, especially in China, and strong performance in the pharmaceutical market drove revenues.
Coming to the price performance, shares of Waters have lost 3.5% over a year compared with the industry ’s decline of 8.9%.
Notably, the company remains optimistic about its strengthening growth initiatives which are likely to aidit in gaining investors’ confidence in the near term as well as the long haul. Further, its new product cycle is also a major positive.
Top Line in Detail
Waters’ net sales figure can be categorized into four ways:
By Operating Segment: The company operates in two organized segments — Waters and TA.
Waters segment (87.4% of net sales) generated $625.1 million of sales, up 3.7% from the year-ago quarter. Sales in TA segment came in $89.9 million and accounted for 12.6% of the net sales. The figure reflected year-over-year growth of 6%.
By Products & Services: This division comprises three segments — Instruments, Services and Chemistry.
Instruments sales (54.8% of sales) came in $392.02 million, up 3.4% on a year-over-year basis.
Service sales (30.3% of the sales) were $216.5 million. The figure increased 4.3% year over year.
Chemistry sales (14.9% of the sales) were $106.5 million, increasing 6% from the year-ago quarter.
Moreover, service and chemistry sections together generated recurring revenues of $323 million, up 5% from the year-ago quarter.
By Markets: The company serves three end markets — Pharmaceutical, Industrial and Governmental & Academic.
Pharmaceutical market (55.5% of net sales) generated sales of $396.9 million, up 6% on a year-over-year basis.
Industrial market (30.7% of sales) sales came in $219.2 million, increasing 1% from the year-ago quarter.
Governmental & Academic (13.8% of sales) generated $98.9 million of sales. The figure was up 2% year over year.
Get The News You Want
By Geography: This company’s operating regions include Asia, Americas and Europe.
Asia (36.8% of net sales) generated $262.9 million of sales for the company. The figure was up 8% on a year-over-year basis, driven by strong momentum in China.
Americas (34.8% of sales) generated $248.5 million of sales, up 5% year over year.
Europe (28.4% of sales) generated $203.6 million of sales, decreasing 3% from prior-year quarter.
Operating Details
In the quarter under review, non-GAAP selling and administrative expenses were $143.05 million, reflecting a decrease of 1.7% year over year but increased 13.3% from the previous quarter.
Further, research and development spendingwas $38.11 million, up 8.5% year over year and 8.3% sequentially.
Adjusted operating margin was 34.5%, expanded 10 basis points (bps) from the year-ago quarter and420 bps sequentially.
Balance Sheet & Cash Flow
As of Dec 31, 2018, cash, cash equivalents and investments came in $1.73 billion, lower than $2.08 billion as of Sep 29, 2018.
Further, total liabilities were $2.16 billion, declining slightly from $2.17 billion in the previous quarter.
Waters also generated free cash flow of $160.3 million in the fourth quarter.
Guidance
For first-quarter 2019, Waters expects non-GAAP earnings in the range of $1.65-$1.75 per share. The Zacks Consensus Estimate for earnings is pegged at $1.78.
The company anticipates net sales growth between 4% and 6% on a constant currency basis. The Zacks Consensus Estimate for sales is currently projected at $546.21 million.
For 2019, Waters anticipates non-GAAP earnings to lie in the range of $9.20-$9.45 per share. The Zacks Consensus Estimate for 2018 earnings is pegged at $9.27 per share.
Further, the company expects net sales to reflect growth between 4% and 6% on a constant currency basis. The Zacks Consensus Estimate is pegged at $2.5 billion.
Zacks Rank & Stocks to Consider
Waters carries a Zacks Rank #3 (Hold).
STMicroelectronics N.V. (NYSE:STM) , Marvell Technology Group (NASDAQ:MRVL) and Pure Storage (NYSE:PSTG) are better-ranked stocks in the broader computer and technology sector. All three sport a Zacks Rank #1 (Strong Buy). You can see Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.